Genotropin Boosts Fertility in American Males with Hypogonadotropic Hypogonadism: 5-Year Study
Reading Time: 2 minutes Introduction Hypogonadotropic hypogonadism (HH) is a condition characterized by deficient gonadotropin secretion, leading to low testosterone levels and impaired fertility in males. In the United States, the prevalence of HH has been a concern, particularly among men seeking to start or expand their families. Genotropin, a recombinant human growth hormone, has emerged as a potential therapeutic agent in this context. This article delves into a comprehensive five-year longitudinal study that evaluates the efficacy of Genotropin in enhancing fertility among American males diagnosed with HH. Study Design and Methodology The study was conducted over five years, involving 150 American males diagnosed...


